|
Description:
|
|
We reviewed the CDA 2013 guidelines on antihyperglycemic therapy for type 2 diabetes (http://guidelines.diabetes.ca/executivesummary/ch13), and explored the pharmacological properties of each of the major classes:
- Biguanides: Metformin
- Sulfonylureas: chlorpropamide, gliclazide, glimepiride, glyburide, and tolbutamide
- Thiazolidinediones: pioglitazone and rosiglitazone
- Meglitinides: Nateglinide and repaglinide
- Alpha-glucosidase inhibitors: Acarbose
- Dipeptidyl Peptidase-4 inhibitors (DPP4 inhibitors): Saxagliptin and sitagliptin
- Glucagon Like Peptide-1 Analogues (GLP-1 analogues): Liraglutide and Exenatide
Drug information:
The post Diabetes 2: antihyperglycemics appeared first on Family Pharm Podcast. |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation